PCSK9抑制剂依洛尤单抗在降低心血管事件风险中的研究进展
陈文文, 李振山, 刘妍妍, 耿涛, 刘燕琳, 党和勤, 景彩
Research progressof evolocumab in reducing risk of cardiovascular events
CHEN Wen-wen, LI Zhen-shan, LIU Yan-yan, GENG Tao, LIU Yan-lin, DANG He-qin, JING Cai
中国医院药学杂志
.
2020, (3): 344
-348
.
DOI: 10.13286/j.1001-5213.2020.03.20
